in this issue
World News and Views :: Top of the News
Johnson Matthey’s JV in China Completes Construction of API Plant
10:48 PM MDT | October 26, 2010 | Deepti Ramesh
Aoxing Pharmaceutical (Shijiazhuang, China) says its previously announced Hebei Aoxing API Pharmaceutical joint venture with Johnson Matthey has recently completed construction of its newly renovated facility, which focuses on research, development, and manufacturing of active pharmaceutical ingredients (API) of narcotics and neurological drugs for the Chinese market. The jv is located in the Hebei Aoxing campus at Xinle, China. Full GMP certification from the State Food and Drug Administration (SFDA; Beijing) and a pharmaceutical business license is expected by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee